Yayınlar & Eserler

Yayın Ağı
Makaleler 31
Tümü (31)
SCI-E, SSCI, AHCI (27)
SCI-E, SSCI, AHCI, ESCI (31)
ESCI (4)
Scopus (29)
TRDizin (5)

1. Comorbidities Are Associated With Unfavorable Outcome in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Exploratory Study From the CROCTINO Cohort

Samadzadeh S., Oertel F. C., Salih H., Lin T., Motamedi S., Chien C., et al.
European Journal of Neurology , cilt.32, sa.6, 2025 (SCI-Expanded) identifier identifier

2. The Effect of Smoking and Passive Exposure on Multiple Sclerosis and Correlation with IL17 & IL23 Levels Multipl skleroz hastalarında tütün tüketiminin hastalık sürecine etkisi ve IL-17 ile IL-23 düzeylerinin korelasyonu

ELMALI YAZICI A. D., Oral G., ORHAN N., Altintaş A.
Noropsikiyatri Arsivi , cilt.62, sa.1, ss.54-61, 2025 (SCI-Expanded) identifier identifier

3. Aquaporin-4 Immunoglobulin G-seropositive Neuromyelitis Optica Spectrum Disorder MRI Characteristics: Data Analysis from the International Real-World PAMRINO Study Cohort

Chien C., Cruz E Silva V., Geiter E., Meier D., Zimmermann H., Bichuetti D. B., et al.
Radiology , cilt.313, sa.2, 2024 (SCI-Expanded) identifier identifier

4. The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?

Sen S., Tuncer A., ÖZAKBAŞ S., Uzunkopru C., Baba C., Demir S., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.58, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

5. Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders

Lu A., Zimmermann H. G., Specovius S., Motamedi S., Chien C., Bereuter C., et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , cilt.93, ss.188-195, 2022 (SCI-Expanded) identifier identifier identifier

6. Temperament and character in relapsing-remitting multiple sclerosis: association with clinical factors and psychiatric disorders

KILIÇ Ö., Celik R. G. G., Emul M., SAİP S., Altintas A., Siva A.
CUKUROVA MEDICAL JOURNAL , cilt.47, sa.3, ss.1339-1349, 2022 (ESCI) Creative Commons License identifier identifier

7. Retinal Optical Coherence Tomography in Neuromyelitis Optica

Oertel F. C., Specovius S., Zimmermann H. G., Chien C., Motamedi S., Bereuter C., et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , cilt.8, sa.6, 2021 (SCI-Expanded) identifier identifier

8. The Complex Genetic Landscape of Hereditary Ataxias in Turkey and Implications in Clinical Practice

Vural A., Simsir G., Tekgul S., Kocoglu C., Akcimen F., Kartal E., et al.
MOVEMENT DISORDERS , cilt.36, ss.1676-1688, 2021 (SCI-Expanded) identifier identifier identifier

9. Risk of secondary progressive multiple sclerosis: A longitudinal study

Fambiatos A., Jokubaitis V., Horakova D., Havrdova E. K., Trojano M., Prat A., et al.
MULTIPLE SCLEROSIS JOURNAL , cilt.26, sa.1, ss.79-90, 2020 (SCI-Expanded) identifier identifier identifier

10. Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO)

Specovius S., Zimmermann H. G., Oertel F. C., Chien C., Bereuter C., Cook L. J., et al.
BMJ OPEN , cilt.10, sa.10, 2020 (SCI-Expanded) identifier identifier identifier

11. Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD

Cook L. J., Rose J. W., Alvey J. S., Jolley A. M., Kuhn R., Marron B., et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , cilt.6, sa.5, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

12. Factors Predictive of Severe Multiple Sclerosis Disease Reactivation After Fingolimod Cessation

Uygunoglu U., Tutuncu M., Altintas A., Saip S., Siva A.
NEUROLOGIST , cilt.23, sa.1, ss.12-16, 2018 (SCI-Expanded) identifier identifier identifier

13. Cytokine Polymorphism and HLA Genotyping in Patients with Temporal Lobe Epilepsy Related to Hippocampal Sclerosis

Altintas A., Ozkara C., Sevindik M. S., Uzan M., Cinar Ç., UYSAL Ö., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.54, sa.4, ss.350-353, 2017 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

14. Catastrophic presentation of a patient with combined NMOSD and thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a case report

Okhovat A. A., Ansari B., Rezaali S., Altintas A., Moghadasi A. N.
ACTA NEUROLOGICA BELGICA , cilt.117, sa.3, ss.757-759, 2017 (SCI-Expanded) identifier identifier identifier

15. Identification of 3 Novel Patients with CLCN2-Related Leukoencephalopathy due to CLCN2 Mutations

Zeydan B., Uygunoglu U., Altintas A., Saip S., Siva A., Abbink T. E., et al.
European Neurology , cilt.78, ss.125-127, 2017 (SCI-Expanded) identifier identifier identifier

16. Next generation sequencing analysis of patients with familial cervical artery dissection

Grond-Ginsbach C., Brandt T., Kloss M., Aksay S. S., Lyrer P., Traenka C., et al.
EUROPEAN STROKE JOURNAL , cilt.2, sa.2, ss.137-143, 2017 (ESCI) identifier identifier identifier

17. NMOSD with an unusual cerebral radiologic manifestation

Moghadasi A. N., Altintas A.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.7, ss.74-75, 2016 (SCI-Expanded) identifier identifier identifier

18. Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome

Disanto G., Adiutori R., Dobson R., Martinelli V., Costa G. D., Runia T., et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , cilt.87, sa.2, ss.126-129, 2016 (SCI-Expanded) identifier identifier identifier

19. Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks

Alroughani R., Altintas A., Al Jumah M., Sahraian M., Alsharoqi I., AlTahan A., et al.
MULTIPLE SCLEROSIS INTERNATIONAL , 2016 (ESCI) Sürdürülebilir Kalkınma identifier identifier

20. Sciatic neuropathy developed after injection during curettage

Altintas A., Gunduz A., Kantarci F., Gozubatik Celik G., Kocer N., Kiziltan M. E.
AGRI-THE JOURNAL OF THE TURKISH SOCIETY OF ALGOLOGY , cilt.28, sa.1, ss.46-48, 2016 (ESCI) identifier identifier identifier

21. Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort Demographic, Clinical, and Laboratory Features

Altintas A., KARABUDAK R., Balci B. P., TERZİ M., Soysal A., Saip S., et al.
NEUROLOGIST , cilt.20, sa.4, ss.61-66, 2015 (SCI-Expanded) identifier identifier identifier

22. Pregnancy Data in a Turkish Multiple Sclerosis Population

Altintas A., Najar B., Gozubatik-Celik G., Menku S. F.
EUROPEAN NEUROLOGY , cilt.74, ss.296-302, 2015 (SCI-Expanded) identifier identifier identifier

23. Familial occurrence and heritable connective tissue disorders in cervical artery dissection

Debette S., Simonetti B. G., Schilling S., Jose Martin J., Kloss M., Sarikaya H., et al.
NEUROLOGY , cilt.83, sa.22, ss.2023-2031, 2014 (SCI-Expanded) identifier identifier identifier

24. Cases of Narcolepsy-Cataplexy Syndrome Following H1N1 Vaccination

Nalbantoglu M., Benbir G., Karadeniz D., Altintas A., Oguz F.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.51, sa.3, ss.283-287, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

25. Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis

Teunissen C., Menge T., Altintas A., Alvarez-Cermeno J. C., Bertolotto A., Berven F. S., et al.
MULTIPLE SCLEROSIS JOURNAL , cilt.19, sa.13, ss.1802-1809, 2013 (SCI-Expanded) identifier identifier identifier

26. Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis: effect of corticosteroid therapy

Seven A., Aslan M., Incir S., Altintas A.
FOLIA NEUROPATHOLOGICA , cilt.51, sa.1, ss.58-64, 2013 (SCI-Expanded) identifier identifier identifier

27. Magnetic resonance imaging of rheumatoid meningitis: a case report and literature review

Hasiloglu Z. I., Asik M., Erer B., Dikici A. S., Altintas A., Albayram S.
RHEUMATOLOGY INTERNATIONAL , cilt.32, sa.11, ss.3679-3681, 2012 (SCI-Expanded) identifier identifier identifier

28. Pathological Contrast Enhancement of the Oculomotor and Trigeminal Nerves Caused by Intracranial Hypotension Syndrome

Albayram S., Asik M., Hasiloglu Z. I., Dikici A. S., Erdemli H. E., Altintas A.
HEADACHE , cilt.51, sa.5, ss.804-808, 2011 (SCI-Expanded) identifier identifier identifier

29. Immunological abnormalities in the patients with autistic regression

Altintas A., Korkmaz B., Poyraz C. A., Ozdemir S., Oguz F., Kekik C., et al.
JOURNAL OF NEUROIMMUNOLOGY , cilt.203, sa.2, ss.192, 2008 (SCI-Expanded) identifier

30. GROUP EXERCISE TRAINING APPROACH TO MULTIPLE SCLEROSIS REHABILITATION

Mutluay F. K., Tekeoglu A., Saip S., Altintas A., Siva A.
NOBEL MEDICUS , cilt.4, sa.3, ss.20-26, 2008 (SCI-Expanded) identifier identifier

31. Pulmonary function in multiple sclerosis without any respiratory complaints

Altintas A., Demir T., Ikitimur H. D., Yildirim N.
CLINICAL NEUROLOGY AND NEUROSURGERY , cilt.109, sa.3, ss.242-246, 2007 (SCI-Expanded) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 21

1. Multipl Skleroz Patogenezinde CD3(-) CD16 ()CD 56 NK Hücrelerinin Fonksiyonel Analizi

TAHRALI İ., KÜÇÜKSEZER U. C., ALTINTAŞ A., UYGUNOĞLU U., DENİZ G.
İmmünolojide Moleküller Sempozyumu, İzmir, Türkiye, 18 Ekim 2018 - 21 Ekim 0018, ss.1, (Tam Metin Bildiri)

2. Increased IL-22 levels in relapsing - remitting Multiple Sclerosis

TAHRALI İ., KÜÇÜKSEZER U. C., AKDENİZ N., ALTINTAŞ A., UYGUNOĞLU U., ÇETİN E., et al.
Abstracts of the 5th European Congress of Immunology-ECI 2018, Amsterdam, Hollanda, 2 - 05 Eylül 2018, cilt.P.C6.06.19, ss.429, (Tam Metin Bildiri)

3. Presentation of Neuromyelitis Optica (NMO) in patients from different racial groups: analysis of the global NMOBase Registry

Kister I., Bacon T., Shaygannejad V., Havrdova E., Alroughani R., TERZİ M., et al.
70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Şili, 21 - 27 Nisan 2018, cilt.90, (Özet Bildiri) identifier

4. Does Co-morbidity with Familial Mediterranean Fever change the course of Multiple Sclerosis?

Siva A., Tutuncu M., Uygunoglu U., Erdogan M., Ugurlu S., Ozcan B., et al.
70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Şili, 21 - 27 Nisan 2018, cilt.90 identifier

5. How to Differentiate Longitudinally Extensive Transverse Myelitis of Neuro-Behcet Syndrome from Neuromyelitis Optica Spectrum Disorders?

Siva A., Uygunoglu U., Zeydan B., Tutuncu M., Ozguler Y., Seyahi E., et al.
9th Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Bangkok, Tayland, 27 - 29 Ekim 2016, cilt.23, ss.342, (Özet Bildiri) identifier

6. The increased IL-22 levels in relapsing-remitting multiple sclerosis.

TAHRALI İ., AKDENİZ N., KÜÇÜKSEZER U. C., Aydın B., UYGUNOĞLU U., ALTINTAŞ A., et al.
3rd International Molecular Immunology & Immunogenetics Congress (MIMIC III), Antalya, Türkiye, 27 - 30 Nisan 2016, cilt.4, sa.1, ss.78, (Tam Metin Bildiri)

7. Rebound of Disease Activity after Fingolimod Discontinuation: Report of Six Cases

Siva A., Uygunoglu U., Tutuncu M., Altintas A., Saip S.
68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Kanada, 15 - 21 Nisan 2016, cilt.86, (Özet Bildiri) identifier

8. Multipl Skleroz hastalarında CD16+CD56soluk ve CD16-CD56parlak NK hücrelerinin farklı sitokin uyarımlarına geç yanıtları

TAHRALI İ., KÜÇÜKSEZER U. C., AKDENİZ N., ÇETİN E., Adaş Ç. U., UYGUNOĞLU U., et al.
23. Ulusal İmmünoloji Kongresi, Antalya, Türkiye, 26 - 30 Nisan 2015, ss.104, (Tam Metin Bildiri)

9. CLIPPERS syndrome: Case report

Altintas A., Alpaslan B. G., Uygunoglu U.
12th International Congress of Neuroimmunology (ISNI), Mainz, Almanya, 9 - 13 Kasım 2014, cilt.275, ss.95 identifier

10. Assessment of aquaporin-4 (AQP4) antibody assays in European diagnostic centres

Waters P., Reindl M., Schanda K., Tuller F., Kral V., Nytrova P., et al.
12th International Congress of Neuroimmunology (ISNI), Mainz, Almanya, 9 - 13 Kasım 2014, cilt.275, ss.15, (Özet Bildiri) identifier

11. Natural killer cells have immune regulatory effects in Multiple Sclerosis

TAHRALI İ., KÜÇÜKSEZER U. C., ÇETİN E., AKDENİZ N., Adaş Ç. U., Yılmaz A., et al.
XXIX Congress of the International Society for Advancement of Cytometry (CYTO 2014), Fort Lauderdale, Amerika Birleşik Devletleri, 17 - 21 Mayıs 2014, ss.172, (Tam Metin Bildiri)

12. Natural Killer Cells: Do they have any immune regulatory effects in Multiple Sclerosis?

Tahralı İ., Küçüksezer U. C., Aktas E., Akdeniz N., Yılmaz A., Adaş C. U., et al.
World Immune Regulation Meeting VIII, 19-22 March 2014,, Chur, İsviçre, 19 - 22 Mart 2014, ss.44, (Tam Metin Bildiri)

13. Multiple Skleroz hastalarında Doğal Öldürücü (NK) Hücre Sitokin içerikleri ve Sitotoksik Yanıtlar.

Tahralı İ., Küçüksezer U. C., Akdeniz N., Çetin E., Yılmaz A., Altıntaş A., et al.
22. Ulusal İmmünoloji Kongresi, Antalya, Türkiye, 27 - 30 Nisan 2013, ss.30, (Tam Metin Bildiri)

14. Characterization of NMO and NMOSD Patients with a Late Onset

Collongues N., Marignier R., Jacob A., Siva A., Paul F., Zephir H., et al.
65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, Amerika Birleşik Devletleri, 16 - 23 Mart 2013, cilt.80 identifier

15. The frequency of inflammatory activity (intrathecal oligoclonal bands and Gd-enhancement in MRI) in German and Turkish MS cases

Tumani H., Altintas A., Nalbantoglu M., Zeydan B., Roesler R., Brettschneider J.
11th International Congress of Neuroimmunology (ISNI), Massachusetts, Amerika Birleşik Devletleri, 4 - 08 Kasım 2012, cilt.253, ss.23, (Özet Bildiri) identifier

16. Immunoregulatory role of Natural killer cells in Multiple Sclerosis

Altintas A., Uygunoglu U., Tahrali I., Kucuksezer U. C., Yilmaz A., Deniz G.
11th International Congress of Neuroimmunology (ISNI), Massachusetts, Amerika Birleşik Devletleri, 4 - 08 Kasım 2012, cilt.253, ss.36, (Özet Bildiri) identifier

17. NMO-spectrum disorders in Turkish population: Clinical, demographic characteristics and the presence of NMO-Ig G

Altintas A., Soysal A., TERZİ M., Isik N., Duman T., Gozubatik-Celik G., et al.
11th International Congress of Neuroimmunology (ISNI), Massachusetts, Amerika Birleşik Devletleri, 4 - 08 Kasım 2012, cilt.253, ss.27, (Özet Bildiri) identifier

18. Kognitif tutulum olan multipl skleroz hastalarında ne yapmalı? Bilgisayar destekli kognitif rehabilitasyon bir tedavi seçeneği olabilir mi?

Topçular B., Bingöl A., Yildiz S., Guclu I., KUŞÇU D. Y., Soysal A., et al.
46. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 4 - 09 Aralık 2010, ss.1, (Tam Metin Bildiri)

19. What to do in multiple sclerosis patients with cognitive involvement? Computer-assisted cognitive rehabilitation: is it a treatment option?

Topçular B., Bingöl A., Yildiz S., Guclu I., KUŞÇU D. Y., Soysal A., et al.
26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis and 15th Annual Conference of Rehabilitation in Multiple Sclerosis, Göteborg, İsveç, 13 - 16 Ekim 2010, ss.76, (Tam Metin Bildiri)

20. The role of Chlamydia pneumonia and human herpes virus 6 in aetiopathogenesis of multiple sclerosis and the relation of multiple sclerosis with apolipoprotein E genotypes

KOCAZEYBEK B., KARATOKA B., ASLAN M., SARIBAS S., ALTINTAŞ A., ERGİN S., et al.
17th ECCMID (European Congress of Clinical Microbiology and Infectious Diseases), Münih, Almanya, 31 Mart - 03 Nisan 2007, cilt.29, sa.2, ss.234, (Tam Metin Bildiri)

21. Prevalence of serum antibodies to hepatitis C virus in patients with multiple sclerosis.

MERT A., Altıntaş A., BİLİR M., ÖZARAS R., TABAK Ö. F., ÖZTÜRK R., et al.
10th European Congress of Clinical Microbiology and Infectious Diseases., Stokholm, İsveç, 28 - 31 Mayıs 2000, cilt.6, ss.151, (Tam Metin Bildiri) Sürdürülebilir Kalkınma
Kitaplar 2

1. Multipl Skleroz: Patolojik Özellikler

ALTINTAŞ A., YAZICI AKKAŞ S., ELMALI YAZICI A. D.
Temel ve Klinik Nöroimmünoloji, Karabudak R, Editör, Ada Basın Yayın Ltd. Şti., Ankara, ss.205-222, 2013

2. Multipl Sklerozda İmmünsüpresif ve Diğer Tedaviler

ALTINTAŞ A., Yandım Kuşçu D., Akman Demir G., ELMALI YAZICI A. D.
Multipl Sklerozda tanı ve tedavi kılavuzu, İdiman E, Karabudak R, Işık N, Siva A., Editör, Galenos Yayınevi, İstanbul, ss.40-56, 2013
Diğer Yayınlar 1

1. Neuropsychological correlates of Multiple Sclerosis

Tekdemir Yurtdaş G., Altıntaş A., Siva A., Townes B. D.
Diğer, ss.22, 1998 Creative Commons License
Metrikler

Yayın

55

Yayın (WoS)

41

Yayın (Scopus)

29

Atıf (WoS)

381

H-İndeks (WoS)

9

Atıf (Scopus)

382

H-İndeks (Scopus)

10

Atıf (Scholar)

19

H-İndeks (Scholar)

2

Proje

2

Açık Erişim

2
BM Sürdürülebilir Kalkınma Amaçları